register

News & Trends - MedTech & Diagnostics

Study validates effectiveness of VR training for surgeons

Health Industry Hub | February 26, 2020 |

MedTech News: The Imperial College London recently conducted an independent study of Johnson & Johnson Institute’s VR (virtual reality) training module on the Anterior Approach to Hip Surgery to illustrate how it can help improve training at the residency level.

In this randomised controlled trial, surgical trainees were either provided conventional training, which includes workshops, lectures, videos from experts, observing and assisting in real surgery, or a five-week VR curriculum. This enabled surgeons to not just practice VR, but also be immediately assessed in VR with feedback and analytics.

The study was published recently in Bone and Joint Journal, showing 83% of surgeons trained on the VR module were able to perform the surgery in a lab setting with minimal guidance, whereas none of the traditionally trained surgeons were able to do the same.

Data from the study shows that even the lowest-scoring VR trained surgeons performed better than the best non-VR-trained surgeon on the module.

“Virtual reality has had a major impact on our surgeons because it mimics a real operating room,” said Dr. Kartik Logishetty, the study’s author and clinical research fellow at Imperial College London. “The environment felt and looked just like real surgery.”

“The data from this study is very promising and propelling us to go even further to scale our VR efforts as evidenced in our two new strategic partnerships with Oculus and Osso VR,” explains Sandra Humbles, Vice President of Global Education Solutions for Johnson & Johnson Medical Devices. “We are now forging ahead with a mission to make VR technology available to surgeons in hospitals to help improve patient outcomes around the world.”

Enhance corporate branding and boost thought leadership to attract and retain quality employees. How does your company culture measure up in the industry, according to results from employee feedback? Get the benchmark analysis by contacting us.

You may also like Medibank management to blame, not medical devices


News & Trends - Pharmaceuticals

Clinicians unveil Novartis and BMS practice-changing trial results

Clinicians unveil Novartis and BMS practice-changing trial results

Health Industry Hub | June 24, 2024 |

Pharma News: Australia, known for its alarming melanoma rates, witnesses one person diagnosed with the disease every 30 minutes, and […]

More


News & Trends - Pharmaceuticals

Hearts4heart leads awareness week, amid progress in Boehringer Ingelheim and AstraZeneca therapies

Hearts4heart leads awareness week, amid progress in Boehringer Ingelheim and AstraZeneca therapies

Health Industry Hub | June 24, 2024 |

Pharma News: Heart failure is a significant health concern in Australia, affecting approximately half a million people, with over 67,000 […]

More


News & Trends - MedTech & Diagnostics

Cardiologists mark Australian first with Boston Scientific's intracoronary imaging system

Cardiologists mark Australian first with Boston Scientific’s intracoronary imaging system

Health Industry Hub | June 24, 2024 |

MedTech & Diagnostics News: Percutaneous coronary intervention (PCI) has faced substantial complications and failure rates, despite advances in medical devices […]

More


Leadership & Management

AbbVie New Zealand welcomes new leadership amid global moves

AbbVie New Zealand welcomes new leadership amid global moves

Health Industry Hub | June 24, 2024 |

Leadership & Management: In line with its global talent development plan, AbbVie has announced a significant change in leadership for […]

More


This content is copyright protected. Please subscribe to gain access.